(Q29615626)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17551515

30 April 2017

1 reference

LaFerla FM

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17551515

30 April 2017

Green KN

series ordinal

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17551515

30 April 2017

Oddo S

series ordinal

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17551515

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17551515

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

July 2007

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17551515

Nature Reviews Neuroscience

30 April 2017

published in

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17551515

30 April 2017

volume

8

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17551515

30 April 2017

issue

7

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17551515

30 April 2017

page(s)

499-509

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17551515

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

30 April 2017

cites work

1 reference

Amyloid plaque core protein in Alzheimer disease and Down syndrome

31 March 2020

1 reference

Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau

31 March 2020

1 reference

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

31 March 2020

1 reference

Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease.

31 March 2020

1 reference

Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease

31 March 2020

1 reference

Oxidative stress hypothesis in Alzheimer's disease

31 March 2020

1 reference

ADAMs family members as amyloid precursor protein alpha-secretases

31 March 2020

1 reference

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

31 March 2020

1 reference

Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase

31 March 2020

1 reference

Purification and cloning of amyloid precursor protein beta-secretase from human brain

31 March 2020

1 reference

Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity

31 March 2020

1 reference

PEN-2 is an integral component of the gamma-secretase complex required for coordinated expression of presenilin and nicastrin

31 March 2020

1 reference

aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation

31 March 2020

1 reference

PS1 N- and C-terminal fragments form a complex that functions in APP processing and Notch signaling

31 March 2020

1 reference

Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing

31 March 2020

1 reference

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

31 March 2020

1 reference

The role of A beta 42 in Alzheimer's disease

31 March 2020

1 reference

Molecular biology and genetics of Alzheimer's disease

31 March 2020

1 reference

The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway

31 March 2020

1 reference

The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation

31 March 2020

1 reference

Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice.

31 March 2020

1 reference

Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase

31 March 2020

1 reference

APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy

31 March 2020

1 reference

Phenotype associated with APP duplication in five families.

31 March 2020

1 reference

Intraneuronal Abeta42 accumulation in Down syndrome brain.

31 March 2020

1 reference

Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease

31 March 2020

1 reference

Pathways by which Abeta facilitates tau pathology

31 March 2020

1 reference

Intraneuronal Abeta42 accumulation in human brain.

31 March 2020

1 reference

Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology

31 March 2020

1 reference

The use of formic acid to embellish amyloid plaque detection in Alzheimer's disease tissues misguides key observations

31 March 2020

1 reference

Intraneuronal amyloid beta42 enhanced by heating but counteracted by formic acid.

31 March 2020

1 reference

Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation.

31 March 2020

1 reference

Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice

31 March 2020

1 reference

The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice.

31 March 2020

1 reference

Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.

31 March 2020

1 reference

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction

31 March 2020

1 reference

Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice.

31 March 2020

1 reference

A dynamic relationship between intracellular and extracellular pools of Abeta

31 March 2020

1 reference

Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration

31 March 2020

1 reference

Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes

31 March 2020

1 reference

Beta amyloid precursor protein mediates neuronal cell-cell and cell-surface adhesion

31 March 2020

1 reference

The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement

31 March 2020

1 reference

Regulated formation of Golgi secretory vesicles containing Alzheimer beta-amyloid precursor protein.

31 March 2020

1 reference

Differential distribution of cellular forms of beta-amyloid precursor protein in murine glial cell cultures

31 March 2020

1 reference

Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides

31 March 2020

1 reference

Intracellular accumulation of beta-amyloid in cells expressing the Swedish mutant amyloid precursor protein.

31 March 2020

1 reference

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

31 March 2020

1 reference

Processing of the Amyloid Protein Precursor to Potentially Amyloidogenic Derivatives

31 March 2020

1 reference

Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42

31 March 2020

1 reference

The low density lipoprotein receptor-related protein 1B retains beta-amyloid precursor protein at the cell surface and reduces amyloid-beta peptide production

31 March 2020

1 reference

Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells

31 March 2020

1 reference

Alzheimer's A beta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells

31 March 2020

1 reference

A detergent-insoluble membrane compartment contains A beta in vivo

31 March 2020

1 reference

Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture

31 March 2020

1 reference

Intracellular generation and accumulation of amyloid beta-peptide terminating at amino acid 42.

31 March 2020

1 reference

Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides.

31 March 2020

1 reference

LRP in amyloid-beta production and metabolism

31 March 2020

1 reference

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

31 March 2020

1 reference

Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease.

31 March 2020

1 reference

Beta amyloid peptide (Abeta42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages.

31 March 2020

1 reference

Abeta peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons.

31 March 2020

1 reference

beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology

31 March 2020

1 reference

Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease

31 March 2020

1 reference

Apolipoprotein E and low density lipoprotein receptor-related protein facilitate intraneuronal Abeta42 accumulation in amyloid model mice.

31 March 2020

1 reference

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

31 March 2020

1 reference

Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease.

31 March 2020

1 reference

Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease

31 March 2020

1 reference

Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease

31 March 2020

1 reference

Regulation of NMDA receptor trafficking by amyloid-beta

31 March 2020

1 reference

Uptake and pathogenic effects of amyloid beta peptide 1-42 are enhanced by integrin antagonists and blocked by NMDA receptor antagonists

31 March 2020

1 reference

Memantine in moderate-to-severe Alzheimer's disease

31 March 2020

1 reference

Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease.

31 March 2020

1 reference

Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function

31 March 2020

1 reference

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

31 March 2020

1 reference

A specific amyloid-beta protein assembly in the brain impairs memory

31 March 2020

1 reference

The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain

31 March 2020

1 reference

Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology

31 March 2020

1 reference

Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain.

31 March 2020

1 reference

Amyloid beta oligomerization is induced by brain lipid rafts

31 March 2020

1 reference

Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease.

31 March 2020

1 reference

Cellular membrane composition defines A beta-lipid interactions

31 March 2020

1 reference

Inhibitors of amyloid β-protein aggregation mediated by GM1-containing raft-like membranes

31 March 2020

1 reference

GM1 ganglioside-mediated accumulation of amyloid beta-protein on cell membranes

31 March 2020

1 reference

Accelerated Abeta aggregation in the presence of GM1-ganglioside-accumulated synaptosomes of aged apoE4-knock-in mouse brain

31 March 2020

1 reference

Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease

31 March 2020

1 reference

Amyloid beta protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein

31 March 2020

1 reference

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

31 March 2020

1 reference

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

31 March 2020

1 reference

Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome

31 March 2020

1 reference

Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease

31 March 2020

1 reference

Amyloid beta-peptide: the inside story

31 March 2020

1 reference

Subcellular topography of neuronal Abeta peptide in APPxPS1 transgenic mice

31 March 2020

1 reference

Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system.

31 March 2020

1 reference

Amyloid beta-protein inhibits ubiquitin-dependent protein degradation in vitro

31 March 2020

1 reference

Amyloid peptide attenuates the proteasome activity in neuronal cells

31 March 2020

1 reference

Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression

31 March 2020

1 reference

Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria

31 March 2020

1 reference

Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease

31 March 2020

1 reference

Mitochondrial dysfunction induced by disease relevant AbetaPP and tau protein mutations.

31 March 2020

1 reference

Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice

31 March 2020

1 reference

Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5

31 March 2020

1 reference

Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory

31 March 2020

1 reference

Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels.

31 March 2020

1 reference

Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats.

31 March 2020

1 reference

A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model.

31 March 2020

1 reference

Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling.

31 March 2020

1 reference

Learning decreases A beta*56 and tau pathology and ameliorates behavioral decline in 3xTg-AD mice.

31 March 2020

1 reference

Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease.

31 March 2020

1 reference

Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol

31 March 2020

1 reference

Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells.

31 March 2020

1 reference

Homocysteic acid induces intraneuronal accumulation of neurotoxic Abeta42: implications for the pathogenesis of Alzheimer's disease

31 March 2020

1 reference

Consistent immunohistochemical detection of intracellular beta-amyloid42 in pyramidal neurons of Alzheimer's disease entorhinal cortex

31 March 2020

1 reference

Lipofuscin and Abeta42 exhibit distinct distribution patterns in normal and Alzheimer's disease brains.

31 March 2020

1 reference

Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization

31 March 2020

1 reference

Abeta42-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease.

31 March 2020

1 reference

Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments

31 March 2020

1 reference

beta-Amyloid precursor protein mRNA is increased in inclusion-body myositis muscle.

31 March 2020

1 reference

Enhanced detection of congo-red-positive amyloid deposits in muscle fibers of inclusion body myositis and brain of Alzheimer's disease using fluorescence technique

31 March 2020

1 reference

31 March 2020

1 reference

Beta-amyloid accumulation in aged canine brain: a model of early plaque formation in Alzheimer's disease

31 March 2020

1 reference

Ultrastructural evidence of fibrillar beta-amyloid associated with neuronal membranes in behaviorally characterized aged dog brains.

31 March 2020

1 reference

p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo.

31 March 2020

1 reference

Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model

31 March 2020

1 reference

Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.

31 March 2020

1 reference

Early intraneuronal Abeta deposition in the hippocampus of APP transgenic mice

31 March 2020

1 reference

Intraneuronal -Amyloid Expression Downregulates the Akt Survival Pathway and Blunts the Stress Response

31 March 2020

1 reference

GRK5 deficiency leads to early Alzheimer-like pathology and working memory impairment.

31 March 2020

1 reference

Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle

31 March 2020

1 reference

Genetically augmenting Abeta42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice

31 March 2020

1 reference

Transgenic expression of beta-APP in fast-twitch skeletal muscle leads to calcium dyshomeostasis and IBM-like pathology

31 March 2020

1 reference

Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the beta-amyloid peptide intracellularly in hippocampal and cortical neurons.

31 March 2020

1 reference

31 March 2020

Inclusion body myositis

1 reference

Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition

31 March 2020

1 reference

Role of microglia in plaque formation in senile dementia of the Alzheimer type. An immunohistochemical study.

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

The non-amyloidogenic pathway: structure and function of alpha-secretases

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17551515

30 April 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1006152248

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17551515

PubMed publication ID

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017